Up to $100,000 is available for drug screening, lead optimisation, pre-clinical testing or other translational activity.
Therapeutic Innovation Australia (TIA) will provide Research Partnership Project Grants of between $10,000 and $100,000 to embark on a program of drug screening, lead optimisation, pre-clinical testing or other translational activity. Applications will be reviewed by the Virtual Pharma Committee, which provides specialized scientific and commercialisation advice to Australian researchers on translation of their research into products for improving human health. The service is free and is aimed at advancing technologies to a stage where they are sufficiently risk minimized for private sector consideration.
The Virtual Pharma mimics the role of the project team that major pharmaceutical companies use for development projects. The Virtual Pharma Committee comprises experts highly experienced in all aspects of product development, with expertise in;
• Target Validation / Biology
• Primary and Secondary Drug Screening
• Translational Chemistry
• Formulation Development and Scale Up
• Pharmacometric Analysis (Modelling and Simulation)
• ADME and Bioanalysis
• GLP and non-GLP Toxicology Testing
• Product Positioning
• Clinical Trials
• Venture Capital and Pharmaceutical Licencing
• Other specialized expertise can be accessed when required
To launch the Virtual Pharma, ITA are awarding Research Partnership Project Grants of between $10,000 and $100,000. The grants will help applicants embark on a programme of drug screening, lead optimisation, pre-clinical testing or other translational activity.
The Virtual Pharma has been established as part of the Translating Health Discoveries Project (THD), a DIISRTE initiative aimed at improving and aggregating Australia’s translational research infrastructure with respect to therapeutics.
Projects must include work that will be undertaken at one of the THD funded capabilities, listed below and on our website The funding for successful applicants will be awarded as an access voucher to be applied at the THD capability. Applications that include matching funding will be favoured.
Applications from researchers at not-for-profit research institutions are eligible. Applicants will normally be expected hold a position of responsibility within the eligible organisation and be able to sign up to and comply with the conditions or terms of the award.
Further details on the application process, including the application form, are available on our website www.therapeuticinnovation.com.au. It is strongly recommended that before applying, interested applicants contact Dr. Stewart Hay, on 03 9670 7018.
For more details about the program, click here.
To download the application form, click here.
Please note that applications for the current round must be received by COB 10 August 2012.